IL6 and Thrombocytosis: In a previous study, the inhibition of thrombopoietin or IL-6 prevented the development of thrombocytosis in mice and significantly enhanced the therapeutic efficacy of paclitaxel in mouse models of epithelial ovarian cancer [24].